Cash · 2017–2025

Aurinia Pharmaceuticals cash

$80.2M−3.9% · FY2025

Aurinia Pharmaceuticals (AUPH) reported $80.2M in cash for fiscal 2025, −3.9% year on year.

$166M2017$118M2018$306M2019$272M2020$232M2021$94.1M2022$48.8M2023$83.4M2024$80.2M2025
Aurinia Pharmaceuticals — Cash, 2017–2025
Fiscal yearCashChangeFiling
FY20252025-12-31$80.2M−3.9%Open →
FY20242024-12-31$83.4M+71.1%Open →
FY20232023-12-31$48.8M−48.2%Open →
FY20222022-12-31$94.1M−59.4%Open →
FY20212021-12-31$232M−14.9%Open →
FY20202020-12-31$272M−11.0%Open →
FY20192019-12-31$306M+159.4%Open →
FY20182018-12-31$118M−28.8%Open →
FY20172017-12-31$166M—Open →

Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth −8.7%

Cash at companies of similar size

Full ranking by cash →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Aurinia Pharmaceuticals cash |url=https://companiesranked.com/en/company/aurinia-pharmaceuticals/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Aurinia Pharmaceuticals cash. CompaniesRanked. https://companiesranked.com/en/company/aurinia-pharmaceuticals/cash-on-hand

BibTeX

@misc{companiesranked-en-company-aurinia-pharmaceuticals-cash-on-hand-2026,
  author       = {{CompaniesRanked}},
  title        = {{Aurinia Pharmaceuticals cash}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/aurinia-pharmaceuticals/cash-on-hand}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001600620-26-000017 · February 26, 2026

{{cite web |title=Aurinia Pharmaceuticals cash — 10-K (0001600620-26-000017) |url=https://www.sec.gov/Archives/edgar/data/1600620/000160062026000017/auph-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Aurinia Pharmaceuticals overview